Open AccessCorrection: Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells
Author(s) -
Håkon Reikvam,
Iepstad,
Øystein Bruserud,
Kimberley Joanne Hatfield
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.14676
Subject(s) - myeloid leukemia , pi3k/akt/mtor pathway , medicine , stromal cell , cancer research , myeloid cells , leukemia , myeloid , bioinformatics , immunology , biology , microbiology and biotechnology , signal transduction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom